266 related articles for article (PubMed ID: 30413806)
1. Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer.
Sherrer RL; Glaser ZA; Gordetsky JB; Nix JW; Porter KK; Rais-Bahrami S
Prostate Cancer Prostatic Dis; 2019 May; 22(2):331-336. PubMed ID: 30413806
[TBL] [Abstract][Full Text] [Related]
2. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinically significant prostate cancer using biparametric magnetic resonance imaging: An evolving concept.
Mahajan M; Gupta V; Gupta P; Sharma P; Abrol D
J Cancer Res Ther; 2022; 18(6):1640-1645. PubMed ID: 36412424
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
6. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
[TBL] [Abstract][Full Text] [Related]
8. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
[TBL] [Abstract][Full Text] [Related]
9. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
[TBL] [Abstract][Full Text] [Related]
10. Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.
Bosaily AE; Frangou E; Ahmed HU; Emberton M; Punwani S; Kaplan R; Brown LC; Freeman A; Jameson C; Hindley R; Peppercorn D; Thrower A; Winkler M; Barwick T; Stewart V; Burns-Cox N; Burn P; Ghei M; Kumaradevan J; Prasad R; Ash-Miles J; Shergill I; Agarwal S; Rosario D; Salim F; Bott S; Evans H; Henderson A; Ghosh S; Dudderidge T; Smart J; Tung K; Kirkham A;
Eur Urol; 2020 Oct; 78(4):503-511. PubMed ID: 32312543
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
12. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
[TBL] [Abstract][Full Text] [Related]
13. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.
Ullrich T; Arsov C; Quentin M; Mones F; Westphalen AC; Mally D; Hiester A; Albers P; Antoch G; Schimmöller L
Eur Radiol; 2020 Nov; 30(11):6042-6051. PubMed ID: 32591887
[TBL] [Abstract][Full Text] [Related]
16. Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
Bao J; Zhi R; Hou Y; Zhang J; Wu CJ; Wang XM; Zhang YD
J Magn Reson Imaging; 2021 Apr; 53(4):1210-1219. PubMed ID: 33075177
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
20. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]